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A B S T R A C T
Idiopathic intracranial hypertension (IIH) is a clinical condition characterized by elevated intracranial pressure and
absence of clinical, laboratory or radiographic evidence of central nervous system infection, vascular malformation, in-
tracranial space occupying lesion or hydrocephalus. In the last years the raising understanding of pediatric IIH, espe-
cially concerning its demographics and epidemiology, has brought up to a redefinition of diagnostic criteria and reevalu-
ation of pathogenesis and treatment. The authors reviewed the records of nineteen consecutive children with newly
diagnosed IIH in order to compare demographic characteristics, clinical pictures and ophthalmologic aspects as optic
disc evaluation and visual field evaluation, as well as treatment modalities and follow up. Beside obesity and female
gender, potential alternative risk factors remains to be investigated, which need a good collaboration between neuro-
ophthalmologists and pediatric neurologists.
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Introduction
Idiopathic intracranial hypertension (IIH) is a clinical
condition characterized by elevated intracranial pressure
and absence of clinical, laboratory or radiographic evi-
dence of central nervous system infection, vascular mal-
formation, intracranial space occupying lesion or hy-
drocephalus1. The incidence of the syndrome is about
1:100,000, with higher prevalence rates, reflecting the
chronic nature of the condition. The pathogenesis of idio-
pathic intracranial hypertension is yet to be clarified but
most theories focuses on the compromised venous blood
flow within the intracranial compartment. In the last
years the raising understanding of pediatric IIH, espe-
cially concerning its demographics and epidemiology, has
brought up to a redefinition of diagnostic criteria and re-
evaluation of treatment modalities. With advances in
neuroimaging and better recognition of etiopathogenetic
mechanisms the diagnostic criteria have been updated:
1) signs and symptoms of raised ICP or papilledema, 2)
CSF opening pressure greater than 250 mm H2O (with
normal composition), 3) absence of hydrocephalus, mass
lesion and structural or vascular lesion on MRI or con-
trast enhanced CT and 4) no other identifiable cause of
intracranial hypertension2. Pediatric IIH is further di-
vided into prepubertal and pubertal forms, based on
development of secondary sexual characteristics or age.
According to the most of published papers there is a net
distinction between the groups in demographic and clini-
cal characteristics. Pediatric IIH patients may present
with systemic complaints such as headache, lethargy,
poor appetite and somnolence while vision complaints
may be overlooked, especially in younger children. Until
recently, VI cranial nerve palsy was the only accepted
neurological abnormality permitted in diagnosing IIH.
Papilledema has generally been considered as a hallmark
physical finding of idiopathic intracranial hypertension
and its severity is positively correlated with the risk of vi-
sual loss. The incidence and type of visual problems in
children are similar to the ones observed in adult pa-
tients. Vision loss in children with IIH is usually mild
and reversible although occasionally it could be devastat-
ing and permanent3. In general, children with idiopathic
intracranial hypertension have a good prognosis and
complete resolution of symptoms, if diagnosed promptly
and treated adequately.
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Patients and Methods
Nineteen consecutive patients age 16 years were
evaluated for a new diagnosis of idiopathic intracranial
hypertension at the Pediatric department of the Univer-
sity Hospital in Rijeka, Croatia, during a 12 years period.
Their medical records were reviewed, and age at diagno-
sis, sex, height and weight, as well as signs and symp-
toms at time of initial examination were recorded. All of
them met the modified Dandy criteria for the diagnosis
of IIH:
1. cranial CT and/or MRI were performed in all cases
in order to confirm the absence of a mass lesion or hydro-
cephalus
2. all of them had an elevated CSF opening pressure
with normal fluid content
3. all patients had a normal result of neurologic exam-
ination with the exception of papilledema, visual distur-
bances or VI nerve palsy
The patients were defined as »pubertal« or »pre-
pubertal« according to the presence of secondary sexual
characteristics, and the term prepubertal was reserved
for patients who had yet to develop any secondary sexual
characteristics.
A standard Body Mass Index was used to determine
obesity4. Patients were categorized as overweight/obese
if their BMI at the time of diagnosis of IIH was over the
85 or 95 percentile value respectively.
All patients underwent complete neuro-ophthalmic
examination including visual acuity and visual field test-
ing. The visual filed was evaluated using the KOWA au-
tomatic visual field plotter. The optic nerve assessment
and grading of papilledema were performed using direct
opthalmposcopy and optic disc edema graded according
to the Frisen scale5.
Results
Demographics
During a twelve years period nineteen children under
16 years of age were admitted to our University Hospital
fulfilling the diagnostic criteria for idiopathic intracra-
nial hypertension. The mean age was 10.7+/–4.07, and
the male-to-female ratio was 6:13. In the prepubertal
group (n=7) the male-to-female ratio was 4:3, whereas in
the pubertal group it was 2:10. We haven’t found any re-
mark in the perinatal and family history of our patients.
Clinical features
The presenting symptoms of our study population are
shown in Tables 1 and 2. There were no asymptomatic
patients. Papilledema was found in eighteen patients.
Neurologic evaluation was normal in fifteen children
while patients had VI cranial nerve paresis. In our study
population we haven’t found any other neurologic abnor-
mality.
Associated conditions
All patients underwent a thorough diagnostic work-
-up in order to exclude any associated medical condition
that could result in a diagnosis of secondary intracranial
hypertension. By that means we have excluded in all of
them any systemic diseases, endocrinology problems,
hematologic conditions as well as electrolyte and/or fluid
dysbalance and renal failure.
Diagnostic procedures
Lumbar puncture was done on all patients. Opening
pressure ranged from 220 to 410 mm Hg with a mean of
295+/–37 mm H2O, with normal cerebrospinal fluid con-
tent in all patients. Four patients had an opening CSF
pressure less than 250 mm H2O. Visual field analysis
were performed in 19 patients, the results are shown in
Table 3. Computed tomography (CT) was done in 5 pa-
tients, magnetic resonance imaging (MRI) was done in
all 19 patients. Visual evoked potentials (VEP) were ana-
lyzed in 14 patients, one patient had a bilateral pro-
longed latency, the others were normal. The EEG finding
was normal in all patients.
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TABLE 1
CLINICAL SYMPTOMS
SYMPTOMS NUMBER %
Headaches 18 94
Nausea/vomiting 10 52
Diplopia 3 16
Visual obscuration 9 47
Somnolence 2 10
Tinnitus 2 10
Neck/shoulder pain 1 5
TABLE 2
WEIGHT DIFFERENCES BETWEEN GROUPS
WEIGHT
TOTAL
(19)
PREPUBERTAL
(7)
PUBERTAL
(12)
Normal
Weight
5 (26 %) 2 (28 %) 3 (25 %)
Overweight 5 (26 %) 2 (28 %) 3 (25 %)
Obesity 9 (48 %) 3 (44 %) 6 (50 %)
TABLE 3
VISUAL FIELD DESCRIPTION
VISUAL FIELD NUMBER %
Normal 5 26
Nasal field deficit 3 16
Blind spot enlargement 8 42
Concentric constriction 3 16
Treatment modalities
All nineteen patients were treated with acetazola-
mide. Additional twelve were treated with topiramat,
chronologically the last 8 patients were treated with both
acetazolamide and topiramat as initial treatment ap-
proach. Corticosteroids were adjunct in 4 patients. No
child underwent any aggressive procedure as serial spi-
nal taping, ventriculoperitoneal shunts or optic nerve
sheath fenestreation.
Clinical course and outcome
Complete resolution of swollen disc findings was ac-
hieved in 12 patients following median treatment du-
raion of 5 months (4–6 months). Seven patients had
peristent optic disc abnormalities. One child had a symp-
tomatic recurrence of IIH resolving after an additional
course of acetazolamide and topiramat. A six months
ophthalmologic follow up has shown a complete regres-
sion of fundus abnormalities in ten patients, while in the
other nine persisted just minor changes of the optic
disk(six with indinstinct disk margins and 3 with pale op-
tic disk).
Discussion
The incidence of pediatric IIH resulting from our
study is 1.2/100 000 which is consistent with the previ-
ously published epidemiologic data. The most common
complaints were headache (18/19), visual disturbances
(12/19) and nausea and vomiting (10/19). In general,
headache is the most common symptom, present virtu-
ally in every patient with IIH. The generalized headache
with morning worsening, typical for IIH, is often accom-
panied by retro-orbital, neck, shoulder and arm pain6.
Headaches in idiopathic intracranial hypertension could
resemble migrainous headaches, although in IIH head-
aches tend to be continuous and less severe than in mi-
graine. It is still unknown why a small number of pa-
tients have an absence of headache, despite an increase
in cerebrospinal pressure.
Three patients presented with sixth cranial nerve
palsy at the time of hospital admission. The reported in-
cidence of this neurological abnormality among children
with IIH varies from 9% to 48%, while palsies of the 3rd,
4th, 7th,9th and 12th cranial nerves, which could be
found in pediatric IIH patients are far less common3,7. It
is still unclear why ocular nerves palsy as well as other
ocular motility disorder like ophtalmoplegia or nystag-
mus are quite frequent among IIH patients since a raised
intracranial pressure could not completely explain the
mechanism of these abnormalities.
Papilledema, as a criterion for the diagnosis, is ob-
served in nearly all patients and is the most important
sign, although the absence of it is not an exclusionary cri-
terion. Clinical examination and subjective grading of op-
tic disc changes is still the most common approach for
evaluation of optic nerve swelling in patients with idio-
pathic intracranial hypertension. New and emerging te-
chniques as Optical Coherence Tomography (OCT) or
Laser Scanning Tomography (LST) seems to be very ef-
fective in optic nerve evaluation8,9. Additional studies are
needed in order to establish the role of these new diag-
nostic tools in the diagnosis and follow-up of papilledema
in children with IIH.
Fifthteen of nineteen patients had some pattern of vi-
sual field defect. One of them had atypical scotoma
whether the others presented with more common visual
field defects as blind spot enlargement, global constric-
tion and nasal field defects. Visual field testing has been
shown to be more sensitive than visual acuity or contrast
sensitivity in detecting visual deficits in adult IIH pa-
tients10. The automated perimetry makes the visual field
assessment more standardized and accurate. Although
most authors agree than the majority of children 4 years
and older are able to perform reliable visual field testing
some authors remain skeptical regarding the age in
which children can cooperate and will not use this me-
thod in children below 8 years of age11.
All patients had a CSF opening pressure of 200 mm
H2O or more, while fifthteen of nineteen had the CSF
pressure over the discriminating value of 250 mm H2O,
according to the modified Dandy criteria. Nevertheless
we are considering all of them over the upper limit for
normal opening pressures, since the majority of pub-
lished data concerning children values, as cited by Fish-
man12 consider 180 mm H2O the upper limit of normal
opening pressure for children less than 8 years of age.
Nevertheless, we haven’t observed in any of them a dra-
matic clinical picture of the so called »fulminant IIH«
which usually could be seen in about 2–3% of patients
with IIH and is characterized by extremely severe visual
loss and need some kind of surgical procedure (optic
nerve sheath fenestration, lumboperitoneal or ventricu-
loperitoneal shunting) to obtain a satisfactory clinical
improvement13. Although no controlled trial has evalu-
ated surgical treatments in IIH there is a general agree-
ment that surgery is indicated in cases of progressive vi-
sual loss14.
In our patients we have found a marked predomi-
nance of obesity and overweight, even in the prepubertal
group. According to previous publications it seems that
pubertal and prepubertal IIH patients differs in demo-
graphic and clinical characteristics, especially concern-
ing the impact of overweight which is so accentuated in
the pubertal patients, similarly to the adults15,16. Unlike
the results of Balcer et al. this investigation, although
the number of patients is restricted, does not provide
strong evidence that in the pediatric age group, younger
patients with IIH are less likely to be obese than are
older children or adults.
Many case reports and case series describe various as-
sociations between intracranial hypertension and certain
medical conditions and medications. The most reported
association of intracranial hypertension is with systemic
diseases as lupus erythematosus17, thyroid gland dys-
function and other endocrinology problems18,19, hema-
tologic conditions20 as well as chronic renal failure21.
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These associations should be described as a secondary
pseudotumor cerebri22 and the term IIH should be re-
served for the purely idiopathic condition. In our case se-
ries we haven’t found any associated medical condition
or pharmacologic treatment so we could say that all of
our patients had a »pure« idiopathic intracranial hyper-
tension. Anyhow, much more information has yet to be
learned regarding the risk factor profile for idiopathic
intracranial hypertension in children. Larger multicen-
tric trials will be needed to examine the potential roles of
metabolic, hormonal or any other physiologic factor in
determining the relation between age and overweight in
pediatric IIH, as well as to search for potential alterna-
tive mechanisms for the development of IIH in nonobese
children.
The patients were treated with acetazolamid and to-
piramat while five patients needed steroid therapy for se-
vere visual disturbances. Traditionally, oral acetazolami-
de, a carbonic anhydrase inhibitor, has been the first-line
medication for inhibiting CSF production. Oral topi-
ramat is a useful adjunct which was found to be equally
efficacious in improving vision, visual fields and optic
disc edema, with a benefit of being a promoter of sub-
stantial weight loss. In our institution, according to a
greater amount of published experiences as well as on
personal experience, we place our IIH patients on both
acetazolamide and topiramate together15. Parenteral cor-
ticosteroid treatment is reserved for patients with severe
visual problems since they can show some temporary
benefit by minimizing further nerve damage in situa-
tions of severe papilledema.
Complete resolution of papilledema was achieved in a
majority of our patients within six months. Nevertheless,
we should take account of seven of our patients with per-
sistent optic disc abnormalities and of one child with
symptomatic recurrence of IIH. According to previously
published paper the optimal duration of follow up is not
yet established. The« Iowa experience« with patients fol-
lowed over ten years shows that IIH can be either a sub-
acute and remitting disorder or take a more chronic
course which justifiy a long-term follow-up care in this
group of patients23.
Conclusions
Among children IIH is a rare condition with a re-
ported incidence of 1/100 000, and a slighter biger preva-
lence indicating the somewhat chronic caracter of the
condition. Potential alternative risk factors remains to
be investigated, which need a good collaboration between
neuroophthalmologists and pediatric neurologists.
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PEDIJATRIJSKA IDIOPATSKA INTRAKRANIJSKA HIPERTENZIJA: KLINI^KA I DEMOGRAFSKA
OBILJE@JA
S A @ E T A K
Idiopatska intrakranijska hipertenzija (IIH) klini~ko je stanje karakterizirano uve}anim intrakranijskim pritiskom
uz odsustvo klini~kih, laboratorijskih ili radiolo{kih elemenata u prilog infekcije sredi{njeg `iv~anog sustava, krvo`ilne
malformacije, intrakranijske ekspanzivne tvorbe ili hidrocefalusa. Posljednjih godina je sve ve}e razumijevanje pedija-
trijske IIH, poglavito na polju epidemiologije i demografskih obilje`ja, dovelo do redefiniranja dijagnosti~kih kriterija
kao i reevaluacije patogeneze i lije~enja. Autori analiziraju demografske zna~ajke te klini~ke karakteristike kao i oftal-
molo{ke aspekte grupe od devetnaestoro djece s idiopatskom intrakranijskom hipertenzijom, uz analizu terapijskih
obilje`ja. Uz prekomjernu tjelesnu te`inu te `enski spol kao poznate ~imbenike rizika, potrebna su daljnja istra`ivanja
mogu}ih rizi~nih faktora za IIH, {to zahtjeva dobru suradnju neurooftalmologa i neuropedijatra.
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